These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 11836703

  • 1. Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples.
    Siddiqui MT, Saboorian MH, Gokaslan ST, Ashfaq R.
    Cancer; 2002 Feb 25; 96(1):49-52. PubMed ID: 11836703
    [Abstract] [Full Text] [Related]

  • 2. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
    Shiran MS, Isa MR, Sherina MS, Rampal L, Hairuszah I, Sabariah AR.
    Malays J Pathol; 2006 Dec 25; 28(2):87-92. PubMed ID: 18376797
    [Abstract] [Full Text] [Related]

  • 3. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.
    Radwan NA, Ahmed NS.
    Diagn Pathol; 2012 Oct 30; 7():149. PubMed ID: 23111165
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology.
    Saad RS, Luckasevic TM, Noga CM, Johnson DR, Silverman JF, Liu YL.
    Diagn Cytopathol; 2004 Jan 30; 30(1):1-6. PubMed ID: 14696137
    [Abstract] [Full Text] [Related]

  • 5. Differential diagnosis of malignant epithelial tumours in the liver: an immunohistochemical study on liver biopsy material.
    Al-Muhannadi N, Ansari N, Brahmi U, Satir AA.
    Ann Hepatol; 2011 Jan 30; 10(4):508-15. PubMed ID: 21911893
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics.
    Fu X, Tan L, Liu S, Li H, Chen L, Qin J, Wu M, Wang H.
    J Cancer Res Clin Oncol; 2004 Sep 30; 130(9):514-20. PubMed ID: 15221469
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Liver Metastases of Neuroendocrine Tumors Rarely Show Overlapping Immunoprofile with Hepatocellular Carcinomas.
    Jin M, Zhou X, Yearsley M, Frankel WL.
    Endocr Pathol; 2016 Sep 30; 27(3):253-8. PubMed ID: 27300354
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Diagnostic utility of immunohistochemistry in hepatocellular carcinoma, its variants and their mimics.
    Wee A.
    Appl Immunohistochem Mol Morphol; 2006 Sep 30; 14(3):266-72. PubMed ID: 16932016
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver.
    Lin F, Abdallah H, Meschter S.
    Diagn Cytopathol; 2004 Feb 30; 30(2):92-7. PubMed ID: 14755758
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.